
Get in the KNOW
on LA Startups & Tech
XHere’s how L.A.’s Curative Plans to Move Saliva-Based COVID-19 Testing to Other U.S. Cities
Rachel Uranga is dot.LA's Managing Editor, News. She is a former Mexico-based market correspondent at Reuters and has worked for several Southern California news outlets, including the Los Angeles Business Journal and the Los Angeles Daily News. She has covered everything from IPOs to immigration. Uranga is a graduate of the Columbia School of Journalism and California State University Northridge. A Los Angeles native, she lives with her husband, son and their felines.

Fred Turner, the 25-year-old founder of Curative Inc., is the man behind L.A.'s push to bring universal testing to the region. But, he has bigger plans.
Turner, an Oxford dropout, just landed a deal with the Air Force to test military worldwide and he's now eyeing national expansion for his startup. By the end of this month, the company he started months ago is expected to pump out more than a million test kits a week.
"We are a strange company because our goal is to essentially put ourselves out of business," Turner said.
Turner, who was named UK Young Engineer of the Year at age 17 when he built a DNA machine from his bedroom to figure out why his brother had red hair and he had brown hair, turned his focus to coronavirus in January. He upended his life as head of Shield Bio, which sought to eliminate sepsis, and moved to Southern California after a local venture capitalist connected him with a lab that he could build out for COVID-19 testing.
Curative Inc. was born.
Curative, Inc. Founder Fred Turner is the man behind L.A.'s push to bring universal testing to the region.
For weeks he lived in hotels as he created what has become the backbone of testing in America's second largest city. The company, one of the few saliva-based tests that have gotten emergency approvals from the FDA, has a 10% false negative rate, according to their own non-peer reviewed studies. Turner argues the rate is better than most of the nasal swab testing out there and oral tests, which can be self-administered, are the only way the country can reopen quickly.
He is now operating two labs, one in San Dimas another in Washington D.C., with plans for several more across the nation. Meanwhile, the rest of the country is watching to see if Los Angeles' promise of universal testing meets the expectations with some already complaining about the difficulty of securing an appointment.
dot.LA: Curative is responsible for 95% of Los Angeles COVID-19 tests. Can you meet the demand for universal testing?
Curative, Inc. Founder Fred Turner: We will be able to fulfill demand. There's more infrastructure that needs to be put in place. With the collection site, the mayor's office has been working hard to scale those up and make sure that the collection site infrastructure is in place. On the lab side, we definitely have enough capacity to serve the area.
In (the San Dimas) lab we have capacity for about 20,000 per day. We're going to be scaling this lab up to 30,000 over the next week or so, eventually, probably slightly more than that.
Ultimately, the goal is to do as many tests as we need to reopen the country and I think we've had many different estimates of how many that might be. I've heard estimates (that it will take) as high as five million tests a day to reopen, but the current supply chain is nowhere near going to be able to keep up with that. The next goal we are shooting for is a million tests a week by about mid-May, end of May.
If we're testing more people will that strain the turnaround time? Right now, I understand it's about 24 to 72 hours. Can you take it down to several hours or even minutes?
We are always aiming to push it down. I think it can be pushed under 24 hours, but we tend to focus more on scaling it up at that point. I think 24 hours is around optimal as you bring on more capacity. We're obviously being careful to match the capacity coming into the lab against the turnaround.
Curative is one of the few companies that the FDA has provided emergency approval for use of a saliva test. Do you think this is the answer to universal testing nationally?
Oral fluids is the technical term, which is slightly different from saliva. Our protocol involves having the person cough first, which releases virus from the upper and lower respiratory tract. Some of that is then caught in the saliva, and also viruses in the saliva. The idea is you're effectively sampling multiple sites at once, which we think gives a slight increase in the sensitivity of the testing.
Self-collected sampling has got to be the way forward. There's just no way that we can do a million nasal pharyngeal swabs, or we call them 'brain swabs,' it's just not practical. We don't have the medical staff, and as a country we just can't do that many swabs. And so the way forward is going to be self collection. That's the only thing we can do at scale.
Covid-19 Oral Fluid Test Kit Instructionswww.youtube.com
Curative recently secured a contract with the Department of Defense. What's next?
We haven't settled on the exact number, but we will be in a large number of states. That is the plan, building out the infrastructure for this kind of testing. We can take the L.A. model and scale it across the country. We have a version of the drive-thru software that other cities and states can take. We have all the training material. We have a team that fly around the country setting up these drive-thru sites. We have really tried to make a plug-and-play package where cities and states that want to launch drive-thru testing, we have everything they need.
Is Los Angeles a testing ground and a proving ground for national efforts?
Yeah, I think Mayor Garcetti has definitely demonstrated what can be done if the city moves very quickly to build out the infrastructure, I do think the drive-thru testing, walk through testing is going to be an essential component of this.
It's just much faster to get the samples to the lab than shipping it out and then shipping it back again. The infrastructure piece is critical for getting these tests out there and we're working with several other states now on building out a similar infrastructure. Some of them have existing programs that we would be plugging into and expanding, and some of them are looking to roll out their own similar programs. You can test a lot more people with the oral tests with far fewer staff.
What are the challenges with the supply chain in terms of making your tests more widely available?
We need more plastic, more robots, more people. Most of the components that go into these tests are just already maxed out in their production capacity. And so we've been throwing online a bunch of internal production, such as injection molding to make our swab kit tubes, as well as bringing on other sources of similar materials that are not being used for COVID-19 testing and validating them for COVID. So for the swabs, for example, we use a swab type that is usually used for testing clean rooms. It works just as well for COVID testing, but nobody else is using it for that purpose.
We don't want to be competing with other people, stopping them from getting access to resources. We want to bring on new supply so it's not a zero- sum game, and the total amount of tests will increase. But, I think distribution is going to be a bigger bottleneck over the next month. Los Angeles has done a fantastic job in building out infrastructure and collection. That needs to happen now across the whole country.
What would it take to meet national demand?
It would take a network of multiple labs that we are calling gigalabs that can process 50,000 to 100,000 tests a day across the country and a significant scale up in the production of the physical components that go into the tests. We've been investigating lab sites in a few states, something central like Texas or Colorado.
Are you concerned that you have too high of a false negative rate at 10%?
All COVID tests will have false negative rates. In our studies, we demonstrated that the sensitivity is at least as good if not better than the nasal pharyngeal swab tests. So, there will definitely be false negatives as there will be in every test, but we think the data supports us having a low rate of false negatives. The sensitivity is about 90%.
When you include all patients, the nasal pharyngeal came in at about 79%. A new (non-peer reviewed) Yale study shows a higher sensitivity from saliva and all fluids than the nasal pharyngeal. I don't think we have the evidence to say that we're better yet, but we have the evidence to say that we're at least equivalent. The ease of doing oral tests and the accessibility is obviously significantly better. We're not using PPE. We're not exposing healthcare workers. It's just a much easier test to roll out that people can test themselves.
File:Florida National Guard (49677710741).jpg - Wikimedia Commonsupload.wikimedia.org
At one point, Curative was attempting to roll out at-home testing and then had to pull back after FDA warnings. Will you be making home testing kits again?
I can't give a time estimate but we are actively working with the FDA right now. I think their concern is "can people adequately collect the sample, or will they do it wrong, and then get a negative test result," which is incorrect. Our plan is to use telemedicine observation. What we've seen in our clinical studies is that if you give people the chance to do it wrong, they will do it wrong. In fact when you have somebody observing, they read the instructions better and they collect a better sample. We're still working on the pricing and potentially looking at whether there is federal or state reimbursement for some of that testing and the potential of billing insurance.
Tracing technology has been promising. Do you have any plans to tie tests to these applications to testing?
We've had several conversations with contact tracing apps and we continue to work in collaboration with public health departments in their contract tracing efforts. Having the test is obviously one thing, but you have to use the information to actually stem the tide of COVID infection. And so, it is an essential step in working closely with various people.
I do like the app-based models where you obviously want to maintain people's privacy, but having people opt-in to share their location history if they test positive so you can contact nearby people.
What does Curative do once there's a vaccine? Are you obsolete?
The U.S. needs to maintain some kind of spare capacity so that next time we are not having to build all of this during a pandemic. But we are a strange company because our goal is to essentially put ourselves out of business. Ultimately, and I say this to everyone we hire, we don't know how long this will go on for. We want to provide as many tests as needed, but the goal is to end COVID and not be doing COVID testing anymore.
Curative took off in March when you arrived in Los Angeles from Silicon Valley, how has the journey been for you personally?
I don't have very much free time, but it's been a lot of fun to be able to work at this pace and have the support of people like the city, the mayor's office to really just do what is needed to scale this up. When we work with suppliers, and we say we're doing COVID testing, they just move heaven and earth to make things happen. It's been really inspiring to be a part of that push forward.
We are just pushing as hard as we can to scale up as fast as we possibly can and bring on as much testing as we can. The city opening up testing to everybody is kind of a culmination of that. We're making about 50,000 kits a day right now and we want to make that as widely available as we can. I would like to get a little more sleep.
The interview has been edited for clarity and brevity.
Correction: An earlier version of this story stated that Curative's saliva tests have a 10% false positive rate. In actuality, the tests have a 10% false negative rate.
Do you have a story that needs to be told? My DMs are open on Twitter @racheluranga. You can also email me.
- coronavirus - dot.LA ›
- coronavirus-tests - dot.LA ›
- curative-inc - dot.LA ›
- Here's How Curative, Inc, Plans to Roll Out Coronavirus Testing to ... ›
- FDA Approves Curative Inc's COVID-19 Test - dot.LA ›
- How One Startup is Preparing for Coronavirus - dot.LA ›
- COVID-19 Test Kit-Maker Curative Inc.is Struggling to Ramp Up - dot ... ›
- How Curative Inc. Plans to Test the U.S. for Coronavirus - dot.LA ›
- Founders and Investors Do Not Share Wall Street's Optimism - dot.LA ›
- Founders and Investors Do Not Share Wall Street's Optimism - dot.LA ›
- Snap Brings Meditation to the Masses - dot.LA ›
- Snap Brings Meditation to the Masses - dot.LA ›
- Curative Founder Fred Turner on Next Steps For COVID Testing - dot.LA ›
- Curative Inc. Brings COVID-19 Testing Kiosks to Los Angeles - dot.LA ›
- Los Angeles Opens COVID Testing Kiosk at Union Station - dot.LA ›
- Los Angeles Opens COVID Testing Kiosk at Union Station - dot.LA ›
- COVID Testing Kiosks Are Heading to LAX - dot.LA ›
- Healthvana Sends Vaccination Records to Apple, Google Wallet - dot.LA ›
- Curative COVID Tests Carry Risk of False Results, FDA Warns - dot.LA ›
- Curative's COVID Tests Will No Longer Be Used in LA County - dot.LA ›
- Curative will Administer Vaccines at Dodger Stadium - dot.LA ›
- A New Coronavirus Vaccine Wants to Take on More Variants - dot.LA ›
- XPrize Awards Winners of COVID-19 Test Competition - dot.LA ›
- The Labs Tasked with Making LA's COVID Testing Mandate Work - dot.LA ›
- Dodger Stadium Reopens Curative COVID Test Site - dot.LA ›
Rachel Uranga is dot.LA's Managing Editor, News. She is a former Mexico-based market correspondent at Reuters and has worked for several Southern California news outlets, including the Los Angeles Business Journal and the Los Angeles Daily News. She has covered everything from IPOs to immigration. Uranga is a graduate of the Columbia School of Journalism and California State University Northridge. A Los Angeles native, she lives with her husband, son and their felines.
Subscribe to our newsletter to catch every headline.
YouTube Shorts Is Big in India—But Can It Dethrone TikTok in America?
Kristin Snyder is an editorial intern for dot.la. She previously interned with Tiger Oak Media and led the arts section for UCLA's Daily Bruin.
YouTube Shorts has gained major traction in India, where its primary competitor, TikTok, is banned—and YouTube executives are hoping the service can parlay that momentum over to the States.
Shorts creators are reaching large audiences in India, a nation of more than 1.4 billion people, the Wall Street Journal reported on Monday. The Google-owned short-form video platform—which recently surpassed 1.5 billion monthly users—initially launched in India in September 2020; within months of that launch, Shorts was racking up more than 3.5 billion views daily, YouTube CEO Susan Wojicki told the Journal. YouTube subsequently rolled out Shorts in the U.S. in March 2021 and has since focused on growing the service as a competitor to TikTok.
While YouTube has not released country-specific user data and metrics, executives told the publication that India remains one of Shorts’ biggest markets. That’s likely been aided by India’s decision to ban TikTok—which is owned by Chinese tech firm ByteDance and bases its U.S. operations in Culver City—in June 2020 due to national security concerns. Data security concerns continue to plague TikTok in the U.S. and other countries where it is allowed to operate, as well.
YouTube Shorts, in turn, continues to gain ground on TikTok. The Journal cited a June survey by data research platform Inmar Intelligence in which more than 29% of respondents identified Shorts as their preferred short-form video service, compared to only 25% in September 2021. TikTok, meanwhile, fell in popularity—with 44% picking it as their top choice in June, compared to 49% in September.
YouTube is now hoping that it can translate Shorts’ success in global markets like India over to the U.S., specifically among the younger users who have driven much of TikTok’s growth. The two firms are already competing on better ways to monetize their platforms for creators, while TikTok recently expanded its maximum video length to compete with YouTube for longer-form content.- TikTok, Snapchat, YouTube and Facebook: Who's Paying What for ... ›
- YouTube, TikTok Amp Up Creator Monetization Race - dot.LA ›
Kristin Snyder is an editorial intern for dot.la. She previously interned with Tiger Oak Media and led the arts section for UCLA's Daily Bruin.
Netflix Facing Another Round of Layoffs: Report
Christian Hetrick is dot.LA's Entertainment Tech Reporter. He was formerly a business reporter for the Philadelphia Inquirer and reported on New Jersey politics for the Observer and the Press of Atlantic City.
Netflix could have another round of layoffs as early as this week, according to Variety.
The streaming giant, which has seen its stock price plummet more than 70% this year, already cut 150 positions across its organization in May. The upcoming layoffs could be similar in size, with impacted employees expected to be informed at the end of this week, Variety reported Monday.
Netflix shares have cratered since the streaming platform reported in April that it lost 200,000 subscribers during the first quarter—the first time that the company shed customers in more than a decade—and expects to shed another 2 million subscribers in the current second quarter. The streamer has blamed heightened competition, password sharing and Russia’s invasion of Ukraine, among other issues, for the loss in customers.
On Netflix’s first-quarter earnings call, CFO Spencer Neumann said that amid slowing revenue growth, the company will look to “protect our operating margins” over the next two years by “pulling back on some of our spend growth across both content and non-content spend.” Netflix began cutting costs a few weeks later, laying off about 25 people in its marketing division, including at its editorial website Tudum.
Although Netflix is navigating unique problems, it is far from the only tech firm that has slashed staff in recent weeks amid increasingly precarious economic conditions.
- Netflix Lays Off 150 Employees - dot.LA ›
- Netflix Hit With Lawsuit Amid Plummeting Stock Price - dot.LA ›
Christian Hetrick is dot.LA's Entertainment Tech Reporter. He was formerly a business reporter for the Philadelphia Inquirer and reported on New Jersey politics for the Observer and the Press of Atlantic City.
LA Tech ‘Moves’: Jam City Shakes Up Games Leaders, Viant Lures Amazon Vet
Kristin Snyder is an editorial intern for dot.la. She previously interned with Tiger Oak Media and led the arts section for UCLA's Daily Bruin.
“Moves,” our roundup of job changes in L.A. tech, is presented by Interchange.LA, dot.LA's recruiting and career platform connecting Southern California's most exciting companies with top tech talent. Create a free Interchange.LA profile here—and if you're looking for ways to supercharge your recruiting efforts, find out more about Interchange.LA's white-glove recruiting service by emailing Sharmineh O’Farrill Lewis (sharmineh@dot.la). Please send job changes and personnel moves to moves@dot.la.
Cash ecosystem integrator Sesami named Nicolas Van Erum as chief marketing officer. Van Erum joins from creative agency Sid Lee.
8minute Solar Energy, a solar and energy storage company, hired Kip Larsonas chief technology officer. Larson previously led technology teams at Amazon and Convoy.
Advertising software company Viant Technology tapped Dustin Kwan as chief product officer. Kwan was most recently general manager of advertising products at Amazon DSP.
Tamara Armstrong joined Loyola Marymount University as chief information officer and vice president for information technology services. Armstrong was most recently associate vice chancellor and CIO at the Los Rios Community College District.
TigerConnect, a health care clinical collaboration platform, hired Melissa Bellas president. Bell was previously chief growth officer for Intelligent Medical Objects.
Visual effects and animation studio DNEG tapped Disney Animation and Dreamworks veteran Erika Burton as co-president of its animation arm.
Video game developer Jam City promoted Lisa Anderson to executive vice president, from her previous role as senior vice president of studio operations. The company also hired Dan Lipa to head its casino division and King’sBrent Blazek to lead its puzzle division.
Seth Rogan’s cannabis lifestyle brand Houseplant brought in Kelly Natenshon as senior vice president of housegoods. Natenshon was most recently a consultant for home brands including California Closets, Cravings by Chrissy Teigen and Wayfair.
Cancer research organization City of Hope named Philip Okala as system president to oversee its portfolio of clinical care and research entities. Okala was previously chief operating officer at the University of Pennsylvania Health System.
Law firm Perkins Coie added attorney Patrick Anding, who has previously provided legal counsel for tech companies, as a partner at its Emerging Companies & Venture Capital practice in its Los Angeles and San Diego offices.
Kristin Snyder is an editorial intern for dot.la. She previously interned with Tiger Oak Media and led the arts section for UCLA's Daily Bruin.